Patterns of invasion and stromal response are understudied in vulvar squamous cell carcinoma. The aim of this study was to explore whether histologic features such as an infiltrative pattern of invasion and fibromyxoid stromal response (FMX-SR) are meaningful prognostic factors. We reviewed 143 vulvar squamous cell carcinoma resections and correlated patterns of invasion and stromal response with patient age, ethnicity, depth of invasion, tumor size, perineural invasion (S100/ AE1/3 stain), lymph node involvement (LNI), extranodal extension, margin status, pathologic stage, and recurrence. Univariate analyses of continuous variables were performed using t tests, whereas Pearson w 2 tests were used for categorical variables. Logistic regression analyses examined the relationship between histopathologic characteristics and clinical outcomes. There was a statistically significant association between infiltrative tumors and an FMX-SR in comparison with noninfiltrative tumors (P < 0.001). Tumors with FMX-SR were significantly more deeply invasive (P = 0.0025) and more likely to have LNI (P = 0.0364), extranodal extension (P = 0.0227), and perineural invasion (P = 0.0011) compared with tumors without FMX-SR. For cases with negative surgical margins, the association between tumors with FMX-SR and LNI was significantly strengthened (odds ratio = 4.73, P = 0.0042), even after adjustments for age, race, and depth of invasion (odds ratio = 4.34, P = 0.0154). The presence of both FMX-SR and an infiltrative pattern of invasion in tumors with negative margins was significantly associated with LNI (P = 0.0235) and recurrence (P = 0.0124). These results suggest that interactions between nerve, tumor, and stromal cells play a role in tumor progression and represent additional prognostic factors that help stratify those patients at highest risk for LNI, extranodal extension, and recurrence.
V ulvar cancer represents 0.3% of all new cancer diagnoses in the United States, and an estimated 4850 new cases were reported in 2014. 1 It is primarily a disease of elderly women, with those between the ages of 75 and 84 most commonly affected. The majority of vulvar cancers (90%) are squamous cell carcinomas. 2 Although a relatively uncommon malignancy, the treatment for vulvar squamous cell carcinoma (vSCC) can be extremely disfiguring. Moreover, tumor recurrence can be a complicating factor, particularly in patients with tumors >2.5 cm, multifocal disease, and involvement of surgical margins, lymphovascular space invasion, or precursor lesions (high-grade squamous intraepithelial lesions, VIN 2/3). 2 Although current clinical criteria for use of adjuvant postsurgical therapy for vSCC patients encompass the presence or absence of nodal involvement, depth of invasion (DOI), and margin status, recurrence rates can reach as high as 50% to 70%. 3, 4 Therefore, a better risk stratification of patients with vSCC is needed.
Studies investigating prognostic factors in patients with vulvar cancer have led to the current staging system, which is based on tumor size (as measured clinically), DOI, extent of regional involvement, and lymph node status. 5 Recent studies in other gynecologic malignancies such as endocervical adenocarcinoma and endometrial carcinoma have focused their attention on patterns of invasion and stromal response to gain a better understanding of tumor behavior in relation to outcome; however, few studies have addressed these histologic features in the arena of vulvar pathology. [6] [7] [8] [9] [10] Although an infiltrative pattern of invasion in vSCC has been frequently cited as an adverse prognostic factor, [11] [12] [13] [14] [15] the literature is particularly sparse with regard to the importance of stromal responses to vSCC. In a review of 51 cases of vSCC, Ambros et al; 16 reported that a subset of vSCCs showed a prominent fibromyxoid stromal response (FMX-SR) and that these tumors were more likely to be associated with women of older age, clitoral involvement, nodal metastasis, and overall poorer survival rates compared with tumors without a prominent FMX-SR. In a larger study of 184 cases of vSCC in Brazilian women, Pinto et al 11 found that an FMX-SR was significantly associated with decreased survival using a univariate analysis but was not significant using a multivariable Cox proportional hazard analysis.
Given the sparse literature on patterns of tumor invasion and stromal response in vSCC, the aim of the current study was to examine the association between these histopathologic features and to assess their prognostic importance in a large series of consecutive resection specimens. Specifically, our study explores whether histologic features such as an infiltrative pattern of invasion and an FMX-SR are meaningful prognostic factors that would potentially allow for better patient risk stratification and more effective treatment planning.
MATERIALS AND METHODS

Clinicopathologic Parameters
A total of 143 cases of invasive squamous cell carcinoma of the vulva were retrieved from our archives. These represented consecutive resection specimens from 128 patients from 1997 through 2013. All available hematoxylin and eosin-stained slides from all cases were reviewed simultaneously by 2 gynecologic pathologists (C.M.Q. and S.K.J.).
Electronic medical records and pathology reports were examined to record patient age, ethnicity, DOI, tumor size, lymph node status, margin status, pathologic stage, recurrence, and clinical follow-up.
Patterns of Invasion
The invasive pattern of the tumors was classified as solid/pushing, nested, or infiltrative (Figs. [1] [2] [3] [4] . Solid/ pushing invasion consisted of tumor growing in a solid sheet, pushing into the underlying stroma ( Fig. 1 ). Nested invasion consisted either of large geographic nests with frequent central comedo-type necrosis (Fig. 2 ) or small nests with frequent central keratin pearls (Fig. 3 ). The infiltrative pattern of invasion was defined by poorly differentiated tumor cells invading the underlying stroma in strands, cords, and single tumor cells creating a spraylike pattern ( Fig. 4 ). Because not all tumors exhibited a single pattern, a secondary pattern was recorded if present. Pattern evaluations were performed at low-power ( Â 4 to Â 10) magnification.
Patterns of Stromal Response
Stromal responses were recorded as present or absent and categorized as: fibromyxoid and/or inflammatory. As previously described, an FMX-SR was defined as extracellular matrix composed of immature collagen and fibroblasts separating and surrounding the tumor cells ( Fig. 5 ). 16 On high-power examination, the myxoid quality of the stroma had a blue hue compared with the background stroma ( Fig. 6 ). Inflammatory stroma was defined as a prominent band-like infiltrate surrounding the tumor, which on high power was composed of lymphocytes and plasma cells ( Fig. 7 ). Stromal response assessments were performed at low power (Â 4 to Â 10 magnification) and confirmed with high-power examination (Â 20 magnification).
Lymph Node Involvement
All hematoxylin and eosin-stained slides from associated lymph node dissections were reviewed. For cases with metastatic involvement, the presence or absence of extranodal extension was documented and correlated with DOI, pattern of invasion, and stromal response of the corresponding primary tumor.
Perineural Invasion
Presence or absence of perineural invasion (PNI) was determined for a subset of our data set (n = 103) as previously described. 17 Briefly, dual-stain immunohistochemistry was performed with antibodies against cytokeratin AE1/3 (Dako M3515) and S100 (Dako Z0311) to identify epithelial and nerve cells, respectively. Each slide was reviewed for the presence of PNI as previously defined, 18 and PNI was correlated with pattern of invasion and stromal response.
Statistical Analysis
Univariate analyses of continuous variables were performed using t tests, and Pearson w 2 tests were used for categorical variables. Logistic regression analyses were used to examine the relationship between histopathologic characteristics (patterns of invasion and stromal response) and the dichotomous clinical outcomes of lymph node metastasis and disease recurrence. P-values <0.05 were considered to be indicative of statistically significant results.
RESULTS
General Clinicopathologic Parameters
Patients ranged in age from 21 to 97 years (mean: 63 y). Of the 128 patients studied, 116 (91%) were white, 11 were African American, and 1 was unknown. Tumor size ranged from 0.3 to 11.0 cm (mean: 3.3 cm), with a DOI that ranged from <1 to 64 mm (mean: 9.6 mm). Margin status was available for 142 cases, 30 of which demonstrated involvement of a surgical margin by tumor. Lymph nodes were sampled in 94 cases, 31 (33%) of which showed squamous cell carcinoma involvement in at least 1 lymph node. Tumor recurrence was noted in 42 (33%) of the 128 identified patients. Clinical stage was available for 137 cases and was distributed as follows: IA-6, IB-73, II-23, III-25, and IV-10. Clinical surveillance data were available for 52% of our patients with a mean follow-up of 28 months and a maximum of 132 months. On the basis of these surveillance data, 21 patients died of disease, 1 died of other cause, 3 are alive with disease, and 41 are alive without disease.
Patterns of Invasion
As described in the Material and methods section, patterns of tumor invasion were categorized as solid/ pushing ( Fig. 1 ), nested (large geographic nests [ Fig. 2 ] or small nests [ Fig. 3 ]), or infiltrative ( Fig. 4 ). Sixty-two (43%) tumors contained an infiltrative pattern of invasion, of which 11 cases were purely infiltrative, with the remainder displaying a mixed pattern (infiltrative component in combination with the solid/pushing or nested pattern). Tumors with any infiltrative component were labeled "infiltrative." Eighty-one (57%) cases lacked an infiltrative pattern and were purely solid/pushing, nested, or a combination of both. These cases were labeled as "noninfiltrative."
The possible association of tumor invasive pattern with stromal response was then analyzed. We found that infiltrative tumors were significantly more often associated with the presence of an FMX-SR than noninfiltrative tumors (54/62 [87%] vs. 13/81 [16%], P < 0.001). In contrast, 70% of the noninfiltrative tumors were accompanied by a prominent inflammatory stromal response compared with only 39% of infiltrative tumors (57/81 [74%] vs. 24/62 [39%], P < 0.001).
To assess the prognostic importance of tumor patterns of invasion, we examined the association of the different tumor patterns with clinical outcomes. We found that infiltrative tumors had a significantly greater DOI compared with noninfiltrative tumors (12.6 vs. 7.3 mm, P = 0.001). Although there was no significant association of tumor pattern of invasion with tumor size or lymph node status, tumors with the presence of any infiltrative component were 2 times more likely to be associated with a recurrence [odds ratio (OR) = 2.15, P = 0.0459] than those without an infiltrative component (Table 1) . This association remained strong when adjusted for age and race (OR = 2.08, P = 0.0571) in a multivariable logistic regression analysis. In cases with negative surgical margins the association between the infiltrative pattern of invasion and tumor recurrence remained strong (OR = 2.31, P = 0.0441) ( Table 2 ).
Patterns of Stromal Response
Stromal responses to the tumor were categorized as fibromyxoid or inflammatory (Figs. 5-7). Sixty-seven (47%) cases showed a prominent FMX-SR, of which 40 were purely fibromyxoid and 27 also contained a prominent inflammatory stroma. When both stromal reactions were present in the same tumor, they were mutually exclusive for any given area (eg, an inflammatory stromal response was never superimposed on an FMX-SR and vice versa). Seventy-six (53%) cases exhibited no FMX-SR, 54 of which showed a prominent inflammatory stroma and 22 had no stromal response.
To assess the prognostic importance of stromal responses, we examined the association of the different stromal responses with clinical outcomes. We found no significant differences that distinguished cases with an inflammatory stroma from cases with no stromal response (neither fibromyxoid nor inflammatory) with respect to any of our recorded clinicopathologic parameters. Therefore, we classified stromal responses as either "fibromyxoid stroma present" or "fibromyxoid stroma absent." Using this classification, there was no significant association of stromal response and tumor size. However, we found that tumors with a fibromyxoid stroma, irrespective of the pattern of tumor invasion, were significantly more deeply invasive (12.2 vs. 7.3 mm, P = 0.0025), more likely to have lymph node involvement (LNI) (20/46 [43%] vs. 11/48 [23%], P = 0.0364), and more likely to recur (25/59 [42%] vs. 17/69 [25%], P = 0.0348) compared with tumors without an FMX-SR (Table 1) . Furthermore, a multivariable logistic regression model showed that tumors with both a fibromyxoid stroma and an infiltrative tumor morphology were 2.7 times (P = 0.0113) more likely to be associated with a recurrence than tumors with either one or neither of those features. This association was observed even after accounting for age, race, and DOI (OR = 2.33, P = 0.0360) ( Table 1) .
When focusing the analysis solely on cases with negative surgical margins, the association between tumors with an FMX-SR and LNI was significantly strengthened (OR = 4.73, P = 0.0042), even after adjustments for age, race, and DOI (OR = 4.34, P = 0.0154) ( Table 2) . However, the significance of association with recurrence was reduced (P = 0.1133) ( Table 2) . Importantly, the presence of both a fibromyxoid stroma and an infiltrative pattern of invasion in tumors with negative margins was significantly associated with both LNI (OR = 3.25; P = 0.0235) and recurrence (OR = 2.88; P = 0.0124) and remained significant after adjusting for age and race ( Table 2 ).
LNI and Extranodal Extension
In addition to assessing LNI, we examined whether the involved nodes had extranodal extension, which is an important indicator for use of adjuvant therapy. Thirtyone of 94 (33%) lymph node dissections showed metastatic disease in at least 1 lymph node. One case represented a fine-needle aspirate and was excluded from the assessment of extranodal extension. Of the remaining 30 lymph node dissections with metastatic disease, the average positive lymph node count was 2.46 (range, 1 to 15) to a total lymph node count of 11.1 (range, 1 to 26). Extranodal extension was present in 17/30 cases (57%). When correlated with DOI, pattern of invasion, or stromal response of the primary tumor, the presence of a fibromyxoid stroma was the only feature of the primary tumor that was significantly associated with extranodal extension in the metastasis (P = 0.0227, Table 3 ).
Perineural Invasion
We have recently associated PNI with tumor recurrence in vSCC, 17 therefore we assessed whether PNI was associated with tumor pattern and stromal response. Tumors with an infiltrative pattern of invasion were significantly associated with PNI compared with noninfiltrative tumors , P = 0.0029); and tumors with both fibromyxoid stroma and an infiltrative pattern of invasion were highly associated with PNI when compared with tumors with 1 of those features or neither (P = 0.0011).
DISCUSSION
Histologic patterns of invasion and their associated stromal responses have recently emerged as a topic of discussion in the literature on gynecologic malignancies such as endocervical and endometrial carcinoma but are relatively understudied in the vulva. [6] [7] [8] [9] [10] In 1987, Ross and Ehrmann 19 studied 64 cases of stage I vSCC. Utilizing the descriptions by Barnes et al, 20 vSCCs were divided according to 3 patterns of invasion: carcinoma in situ with early stromal invasion, pushing, and infiltrative. The pushing pattern was defined by a broad, smooth front of invasion and dissociated nests, the infiltrative pattern by ribbons, cords, or single cells. In their study, patients with carcinoma in situ with early stromal invasion had low risk for LNI and no increased recurrence risk. In addition, the pushing pattern of invasion was a favorable histologic feature, whereas the infiltrative pattern of invasion was predictive of LNI. Additional research has shown that the infiltrative pattern of invasion is associated with a higher likelihood of LNI and decreased overall survival; however, stromal responses to vSCC have been relatively understudied. [12] [13] [14] [15] In a review of 51 vSCC cases, Ambros et al 16 observed that a subset of vSCC showed a prominent FMX-SR, which they defined as a well-demarcated stromal reaction that consisted of a prominent extracellular matrix composed of immature collagen and fibroblasts separating the tumor cells. The authors semiquantitatively categorized the extent of this stromal response as focal (< 25%), regional (26% to 50%), or diffuse (> 50%). The FMX-SR was identified in over half of cases with a focal, regional, and diffuse distribution of 21%, 14%, and 16%, respectively. The remaining cases showed no FMX-SR. There was no statistically significant difference when the FMX-SR was categorized as "present" or "absent" and correlated with other clinicopathologic features including age, tumor location, gross appearance (exophytic or ulcerative), tumor grade, tumor size, DOI, pattern of invasion (pushing, raggedly infiltrative, or mixed), type of vSCC (typical, basaloid, warty), lymph node status, recurrence, and overall survival. However, there were significant correlations when tumors with a focal FMX-SR (< 25%) were excluded from the analysis. Specifically, tumors with a prominent FMX-SR (> 25%) were more likely to be associated with older age, clitoral involvement, nodal metastasis, and overall poorer survival rates compared with tumors without a prominent FMX-SR. The authors concluded that only tumors with a prominent fibromyxoid stromal reaction might represent an aggressive subset of vSCC.
Pinto et al 11 studied the clinicopathologic features of vSCC in Brazilian women in a study of 184 cases. The authors examined the potential correlations between age, tumor grade, thickness, histologic pattern (warty/basaloid or keratinizing), pattern of invasion (blunt/nested, infiltrative, or mixed), stromal response (fibromyxoid or inflammatory), human papillomavirus (HPV) status, pathologic stage, and overall survival. Increasing age, stage, grade, tumor thickness, and basaloid histology were each independently correlated with decreased survival. In addition, there was an association of the infiltrative pattern of invasion with increased mortality. Although an FMX-SR was associated with a worse outcome in a univariate analysis, this association was not significant in a multivariable Cox proportional hazard analysis that adjusted for age, stage, tumor thickness, histologic type, pattern of invasion, number of keratin pearls, and HPV status. Importantly, Pinto and colleagues did not investigate the association of either invasive pattern or stromal response with tumor recurrence or nodal involvement.
Given this context, we reviewed 143 consecutive resection specimens of vSCC and explored the prognostic significance of patterns of invasion (infiltrative vs. noninfiltrative) and stromal response (fibromyxoid stroma present vs. absent). Our study is the first to report a strong association between tumors with an infiltrative pattern and an FMX-SR. In addition, our results show that the presence of any infiltrative component in vSCC is significantly associated with more deeply invasive tumors and increased risk for recurrence compared with noninfiltrative tumors. Tumors lacking an infiltrative component (solid/pushing or nested tumors) were much more likely to demonstrate a prominent inflammatory infiltrate and a shallower DOI. Moreover, in contrast to the findings of Ambros et al, 16 our results show that the presence of any fibromyxoid stroma is an adverse prognostic factor, irrespective of the pattern of invasion. Specifically, tumors with an FMX-SR were more deeply invasive and more likely to involve lymph nodes. The latter remained significant even after adjustment for age, race, DOI, and margin status in a multivariable analysis. Further, when nodal metastasis was present, tumors with a fibromyxoid stroma were more likely to demonstrate extracapsular extension. This is highly relevant because the presence of extracapsular extension is a reportable prognostic factor that is associated with poor outcome and independent indicator for increased dosage of adjuvant radiation. Although we report a strong association between an infiltrative pattern of invasion and an FMX-SR, a small number (8) of pushing tumors also contained an FMX-SR. Of these tumors, 50% (4 of 8) had LNI and were more likely to be associated with extracapsular extension, suggesting that stromal interactions may play a large role in the mechanism of tumor invasiveness. In addition to pattern of invasion and stromal response, we recently identified that PNI represents an independent risk factor for recurrence in vSCC. 17 Utilizing a dual immunostain (S100/AE1/3), we showed that both the infiltrative pattern of invasion and a fibromyxoid stroma are strongly associated with PNI. The association of PNI, infiltrative pattern of invasion, and FMX-SR in vSCC suggests that interactions between nerve, tumor, and stromal cells play a role in progression and recurrence of this cancer. The interplay among these cells will be a focus of future studies.
The ability of a tumor to invade and metastasize is partly due to its relationship with the surrounding stroma. Tumor-stromal interactions in vSCC are currently poorly understood. The specific cellular interactions that trigger a well-differentiated solid/pushing or nested tumor to become poorly differentiated and infiltrative remain to be explored. In addition, why infiltrative tumors show such a high association with the FMX-SR is also a question requiring more inquiry. Therefore, more research is needed to define the tumor-stroma interactions in vSCC at the cellular level.
A major strength of our study is its large sample size (143 cases) of consecutive resection specimens. In addition, we purposefully chose not to semiquantitatively assess patterns of invasion or stromal response as was done in previous studies. In surgical pathology, it is most practical when a specific parameter is assessed as "present" or "absent." Hence, we chose to analyze our data in this regard: infiltrative pattern present or absent as well as fibromyxoid stroma present or absent. Our results indicate that low-power recognition of any infiltrative pattern and any FMX-SR is important. This contrasts to previous studies by Ambros and colleagues and Pinto and colleagues in which the FMX-SR was assessed in a semiquantitative manner and only reached statistical significance when it was regional or diffuse (> 25%). This should prompt the surgical pathologist to focus not only on tumor morphology but also quality of the stroma.
Because of its retrospective design, our results are limited by the lack of clinical follow-up and information related to HPV status, tumor grade, and precursor lesions. The importance of HPV status and tumor grade as prognostic factors in vSCC remains controversial because conflicting results have been reported. 11, 21, 22 Regarding tumor grade, a uniform grading system for vSCC has not been unanimously accepted, and grading has not been shown to demonstrate prognostic significance. 23 Precursor lesions correlate with the histologic type of vSCC, and a significant correlation between lichen sclerosus and subsequent vSCC with an FMX-SR has been reported. 24 More studies are needed to address the interactions between HPV status, precursor lesions, pattern of invasion, and stromal response in relation to tumor behavior, and we hope to address several of these issues in subsequent projects.
In summary, we are the first to report that an FMX-SR is highly associated with an infiltrative pattern of invasion and PNI in vSCC. In addition, the results of our study indicate that tumors with an infiltrative pattern of invasion, an FMX-SR, and PNI represent an important subset of vSCCs that behave more aggressively. In particular, an infiltrative pattern of invasion and PNI are highly associated with an increased risk for tumor recurrence, whereas an FMX-SR is associated with increased risk for nodal metastases. These additional prognostic factors may help stratify those patients at highest risk for LNI, extranodal extension, and recurrence. A better stratification of risk will be valuable in surgical planning and in increasing the effective use of adjuvant therapy.
